CVRx® Launches HOPE4HF™ Clinical Trial Evaluating Barostim neo™ in Heart ... PR Newswire (press release) The study is evaluating the effectiveness and safety of CVRx's Barostim neo in heart failure patients. Dr. Richard Abben , Director of Cardiac Intervention, with the Cardiovascular Institute of the South, in Houma, Louisiana is the Principal ... |
